Steatotic liver disease after pediatric liver transplantation
- 9 June 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (1) , 65-72
Abstract
Metabolic dysfunction–associated steatotic liver disease is becoming an increasingly frequent cause of chronic liver disease in children. It has been reported as a complication of liver transplantation in adults but remains poorly evaluated in liver-transplanted children. The aim of this study was to assess the prevalence and characteristics of steatotic liver disease in a large cohort of liver-transplanted children and to identify factors associated with it. In this single-center study of patients with pediatric liver transplants (n=122) with a median follow-up time of 14.0 years, steatosis was found in 41 protocol biopsies (33.6%). The median time to the discovery of steatosis was 5.0 years posttransplantation, with a median age of 9.0 years at the time of diagnosis. Steatosis was predominantly mild to moderate and tended to resolve spontaneously on subsequent biopsies (48.8% of cases showed resolution). Steatosis mostly corresponded to metabolic dysfunction–associated steatotic liver disease (56.1%), but other patients had cryptogenic steatosis. The study found no association between the presence of steatosis and the immunosuppressive regimen, but a significant association between the onset of steatosis and an older donor age ( p <0.001). Therefore, steatotic liver disease is a noteworthy histological feature during the follow-up of pediatric liver transplant recipients, yet it had a low burden on the health of the patients in this cohort. However, it needs to be monitored in the context of the increasing prevalence of metabolic syndrome.Keywords
This publication has 22 references indexed in Scilit:
- The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adultsJournal of Pediatric Gastroenterology and Nutrition, 2024
- Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclatureJournal of Pediatric Gastroenterology and Nutrition, 2024
- Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosisJHEP Reports, 2023
- Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and EvolutionLiver Transplantation, 2021
- Hepatic steatosis after pediatric liver transplantLiver Transplantation, 2017
- Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk FactorsThe Journal of Pediatrics, 2017
- Low-dose steroids associated with milder histological changes after pediatric liver transplantationLiver Transplantation, 2012
- Metabolic syndrome: Is immunosuppression to blame?Liver Transplantation, 2011
- Progressive histological damage in liver allografts following pediatric liver transplantationHepatology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005